Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Regencell's Standardized TCM Formula is an investigational, liquid-based traditional Chinese medicine (TCM) herbal mixture being developed by Regencell Bioscience for the treatment of neurocognitive disorders, specifically attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The formula is administered orally and is designed based on the Sik-Kee Au TCM Brain Theory, which posits that neurocognitive disorders stem from inadequate blood flow and neurotransmitter production in the developing brain. It utilizes combinations of natural herbal categories to address the underlying causes of these disorders without a disclosed molecular target. The candidate is currently undergoing efficacy trials in Hong Kong.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Regencell's Standardized TCM Formula.